Prostate cancer screening: massive study gets minimal coverage. Why?

The largest-ever randomized trial of using the prostate-specific antigen (PSA) test in asymptomatic men over the age of 50 has found — after about 10 years of follow-up — no significant difference in prostate cancer deaths among men who were screened with a single (“one-off”) PSA test, and those who weren’t screened.

The findings come from a British study called CAP (“Cluster Randomized Trial of PSA Testing for Prostate Cancer”) published earlier this week in JAMA.

Two things...

What feeling does this article give you?

#hashtags to follow:

PSA [+]    Prostate Cancer [+]    JAMA [+]   

More #news: